Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,246 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interleukin-23 inhibitors decrease Fibrosis-4 index in psoriasis patients with elevated Fibrosis-4 index but not inteleukin-17 inhibitors.
Takeshima R, Kamata M, Suzuki S, Ito M, Watanabe A, Uchida H, Chijiwa C, Okada Y, Azuma S, Nagata M, Egawa S, Hiura A, Fukaya S, Hayashi K, Fukuyasu A, Tanaka T, Ishikawa T, Tada Y. Takeshima R, et al. Among authors: okada y. J Dermatol. 2024 Sep;51(9):1216-1224. doi: 10.1111/1346-8138.17277. Epub 2024 May 28. J Dermatol. 2024. PMID: 38804254
Erythema multiforme after initiating spesolimab in a patient with generalized pustular psoriasis with IL36RN mutation.
Nakajima H, Kamata M, Okada Y, Ito M, Watanabe A, Azuma S, Uchida H, Egawa S, Chijiwa C, Hiura A, Fukaya S, Hayashi K, Fukuyasu A, Tanaka T, Ishikawa T, Sugiura K, Tada Y. Nakajima H, et al. Among authors: okada y. Eur J Dermatol. 2024 Jun 1;34(3):324-325. doi: 10.1684/ejd.2024.4711. Eur J Dermatol. 2024. PMID: 39015980 No abstract available.
Possibility of maintaining remission with topical therapy alone after withdrawal of dupilumab in Japanese patients with atopic dermatitis and their characteristics in the real world.
Watanabe A, Kamata M, Okada Y, Suzuki S, Ito M, Uchida H, Chijiwa C, Egawa S, Hiura A, Fukaya S, Hayashi K, Fukuyasu A, Tanaka T, Ishikawa T, Tada Y. Watanabe A, et al. Among authors: okada y. Exp Dermatol. 2024 Sep;33(9):e15175. doi: 10.1111/exd.15175. Exp Dermatol. 2024. PMID: 39277874
Serum interleukin-10 level is increased and correlated positively with disease severity in patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid.
Suzuki S, Kamata M, Uchida H, Shimizu T, Okada Y, Ito M, Watanabe A, Mizukawa I, Egawa S, Chijiwa C, Hiura A, Fukaya S, Hayashi K, Fukuyasu A, Tanaka T, Ishikawa T, Tada Y. Suzuki S, et al. Among authors: okada y. J Dermatol. 2025 Jan;52(1):122-131. doi: 10.1111/1346-8138.17512. Epub 2024 Oct 20. J Dermatol. 2025. PMID: 39428667
Real-World Experience of 3-Year Treatment With Dupilumab: Significant Decrease in Circulating Neutrophils and Eosinophils in Japanese Patients With Atopic Dermatitis.
Nakajima H, Kamata M, Okada Y, Suzuki S, Ito M, Watanabe A, Egawa S, Chijiwa C, Hiura A, Tomura Y, Fukaya S, Hayashi K, Fukuyasu A, Tanaka T, Ishikawa T, Tada Y. Nakajima H, et al. Among authors: okada y. Exp Dermatol. 2024 Nov;33(11):e70010. doi: 10.1111/exd.70010. Exp Dermatol. 2024. PMID: 39487715
Colorectal anastomotic leakage after conversion surgery for advanced endometrial cancer treated with lenvatinib plus pembrolizumab: a case report.
Yamamura A, Hamanishi J, Yamanoi K, Sunada M, Taki M, Mizuno R, Okada Y, Murakami R, Aisu Y, Maekawa H, Yamaguchi K, Mandai M. Yamamura A, et al. Among authors: okada y. Int Cancer Conf J. 2024 Dec 10;14(1):64-71. doi: 10.1007/s13691-024-00739-6. eCollection 2025 Jan. Int Cancer Conf J. 2024. PMID: 39758791 Free PMC article.
7,246 results